Current methods to treat large soft-tissue defects mainly rely on autologous transfer of adipocutaneous flaps, a method that is often limited by donor site availability. Engineered vascularized adipose tissues can potentially be a viable and readily accessible substitute to autologous flaps. In this study, we engineered a small-scale adipose tissue with pre-patterned vasculature that enables immediate perfusion. Vessels formed after one day of perfusion and displayed barrier function after three days of perfusion. Under constant perfusion, adipose tissues remained viable and responded to lipoactive hormones insulin and epinephrine with lipid accumulation and loss, respectively. Adipocyte growth correlated inversely with distance away from the feeding vessel, as predicted by a Krogh-type model.
Introduction
Large soft-tissue defects often accompany traumatic injury, tumor resection, or diabetic foot. The current gold standard for reconstruction of these defects is autologous tissue transfer of adipocutaneous flaps [1] . This technique is limited by tissue availability and may result in donor-site morbidity. The engineering of a stable and functional adipose tissue that can be grafted as a perfused unit could be invaluable for treating softtissue defects [2, 3] .
Studies have shown that immediate perfusion is absolutely required for survival of free flaps and transplanted tissue, unless the tissue is extremely thin [4, 5] . Free fat grafting by lipoinjection, which disrupts the native adipose vasculature and cannot establish immediate perfusion, often fails to maintain volume over time [6, 7] . Therefore, it is crucial for engineered adipose tissue to not only have a preformed vasculature, but one that is perfused. Most studies to engineer vascularized fat tissue have employed a combination of angiogenic and adipogenic growth factors, a suspension of endothelial cells (ECs) and adipocytes and/or adipocyte progenitors, and an appropriate scaffold [8] [9] [10] . The vasculature in these engineered tissues forms by angiogenesis and/or vasculogenesis, which typically require one or more weeks and can yield a poorly organized microvascular network.
Moreover, the small diameter of these microvessels makes cannulation and surgical anastomosis impossible, and it is unclear how to establish perfusion during tissue maturation in vitro and upon grafting in vivo . Insertion of an arteriovenous bundle into the developing construct can provide a vascular pedicle for surgical anastomosis, but even here, generation of vascularized fat requires weeks [11] .
With few exceptions, studies of engineered adipose tissue have focused primarily on characterizing the structure of the tissue histologically and have confirmed the presence of adipocytes by staining with lipid markers such as Oil Red O [12] . Along with its structural role, however, adipose tissue plays critical metabolic and endocrine roles that depend on signals from adjacent ECs that line their lumens [13] . Insulin has been shown to upregulate lipogenesis both by increasing uptake of free fatty acid [14] and by increasing conversion of triacylglycerol into fatty acid by lipoprotein lipase that is expressed on the surface of ECs [15] . Conversely, β-adrenergic agonists such as epinephrine have been shown to upregulate lipolysis by stimulating the activity of hormone-sensitive lipase [16] . It is important to demonstrate that engineered adipose tissue responds to lipoactive hormones in a physiologically relevant manner [17] .
The objective of the current study was to engineer a vascularized adipose tissue that could be immediately and constantly perfused and that demonstrated lipoactivity. The methods described here built upon previously described techniques to vascularize microfluidic collagen scaffolds [18] , and yielded a 'fundamental unit' of adipose tissue that contained one microvessel that perfused an adipocyte-laden collagen gel. We showed that the microvessel within the engineered adipose tissue possessed good barrier function, and that the adipocytes responded appropriately to vascular perfusion with lipoactive hormones.
Methods

Cell culture
Mouse 3T3-L1 preadipocytes (ATCC) were grown in high-glucose DMEM (Invitrogen) supplemented with 10% heat-inactivated fetal bovine serum (FBS; Atlanta Biologicals) and 1% glutamine-penicillin-streptomycin (GPS; Invitrogen) ('basal medium'). The 3T3-L1 cells were routinely passaged at 1:10 ratio and were used up to passage nine.
To differentiate 3T3-L1 cells, we switched cultures two days post-confluence, to 'differentiation medium': basal medium supplemented with 0.25 μM dexamethasone, 2 μM rosiglitazone, 10 μg ml −1 insulin, 0.5 mM 3-isobutyl-1-methylxanthine, and 0.2 mM ascorbic acid 2-phosphate (all from Sigma) [19] . After another two days, differentiation medium was replaced with 'maintenance medium': basal medium supplemented with 10 μg ml −1 insulin only.
Human dermal microvascular ECs (PromoCell) were grown on gelatin-coated dishes in MCDB131 medium (Caisson) that was supplemented with 10% FBS, 1% GPS, 1 μg ml −1 hydrocortisone (Sigma),
EC growth supplement (Alfa Aesar), 2 U ml -1 heparin (Sigma), and 0.2 mM ascorbic acid 2-phosphate ('EC culture medium'). ECs were routinely passaged at a 1:4 ratio and were used up to passage nine.
Formation of vascularized adipose tissues
Adipose tissues that contained a single microvessel (n=57) were formed using a modified procedure from a previous study [18] . Briefly, a stainless steel needle of 120 μm in diameter (Seirin) was positioned at the center of a 1 mm×1 mm×7 mm chamber in silicone (PDMS) mold. Rat tail type I collagen (diluted to 6 mg ml −1 before mixing with cells; Corning) was neutralized to pH 7. Confluent 3T3-L1 cells were trypsinized 6-7 days after start of differentiation and centrifuged at ∼120 g for three minutes, yielding a cell pellet that was ∼15 μl. The cell pellet was gently mixed with 375 μl neutralized collagen to yield a density of ∼10 6 cells ml
, and was gelled for thirty minutes at room temperature in the chamber around the needle; the final concentration of collagen was ∼5.8 mg ml −1 .
This collagen concentration was high enough to inhibit vascular sprouting [18] without limiting adipocyte growth. The needle was removed, and the resulting channel was then seeded with ECs. Perfusion was set up in the microscale tissue by connecting each end of the channel to a reservoir of EC culture media that was supplemented with 3% dextran (70 kDa; Sigma) ('perfusion media'). A pressure difference of 4.5 cm H 2 O was maintained for up to seven days. Perfused adipose tissues were kept at 37°C in 5% CO 2 and refed twice daily ( figure 1) . As a control, some gels (n=8) were formed and vascularized without the addition of adipocytes.
To form larger tissues (n=17), we used wider chambers (1 mm×11 mm×6 mm) to hold the needle; the needle was placed 0.5 mm away from one edge of the chamber before adding the adipocyte-containing collagen. Here, the cell density was 10 6 cells ml -1 or 1.5×10 6 cells ml 
Hydraulic permeability and stiffness assays
To measure the hydraulic permeability of adipocytecontaining and cell-free collagen gels, we gelled collagen with and without 10 6 3T3-L1 cells ml -1 in PDMS molds to form 1 mm×1 mm×7 mm solid gels. On days 1 through 5 after gelling, perfusion media that was supplemented with 10 μg ml −1 insulin and 0.5 mg ml −1 Intralipid (Sigma) was allowed to flow through the gel for two hours under an applied pressure difference of 1-1.1 cm H 2 O. The hydraulic permeability coefficient k was calculated using equation (1) , where Q is the flow rate of the media, A is the cross-sectional area of the gel, ΔP is the pressure difference, and L is the length of the gel:
To measure the stiffness of adipocyte-containing and cell-free collagen gels, we formed disc-shaped collagen gels with and without 10 6 3T3-L1 cells ml -1 in a cylindrical mold that was 6 mm in diameter and 2 mm in height. Gels were again kept in perfusion media that was supplemented with 10 μg ml −1 insulin and 0.5 mg ml −1 Intralipid. On days 1, 3, and 5 after gelling, each gel was submerged horizontally in phosphate-buffered saline (PBS), and an aluminum ball with diameter of 1.6 mm (Precision Balls) was placed on the upper surface of the collagen. After one hour, the indentation of the aluminum ball was measured, and the stiffness was calculated as indentation modulus using equation (2), where R and ρ are the radius and density of the aluminum ball, respectively, ρ PBS is the density of PBS, δ is the indentation depth, and g is 9.8 m s −2 [20] :
Lipogenesis and lipolysis assay
After vascularized adipose tissues were perfused for one day, the perfusion media was supplemented with −1 insulin and 0.5 mg ml −1 Intralipid. Intralipid is an emulsion of lipid that is used for parenteral nutrition and has been shown to increase the accumulation of lipids in adipocytes in planar culture [21] . After another four days of perfusion (i.e., on day 5 of perfusion), tissues were then switched to perfusion with insulin-and Intralipid-free media with or without 10 μM epinephrine for an additional four days (i.e., to day 9 of perfusion). Phase-contrast images were taken on days 1, 3, 5, 7, and 9 of perfusion, and the lipid droplet area per cell was measured manually for 30-40 adipocytes per tissue. The results were compared between tissues with or without insulin/ Intralipid for days 1-5 and between tissues with or without epinephrine for days 5-9. Images were obtained with a 10×/0.30 Plan-Neofluar objective on a Zeiss Axiovert 200M microscope at 1300×1030 camera resolution. All lipid droplet measurements were performed in a blinded manner.
Wide tissues that contained 10 6 or 1.5×10 6 3T3-L1 cells ml -1 and a single vessel were perfused for seven days, the last six with media that was supplemented with 10 μg ml −1 insulin and 0.5 mg ml
Intralipid. On days 1, 3, 5, and 7 of perfusion, phasecontrast images of adipocytes that were at different distances from the vessel (0-1 mm, 1-2 mm, etc) were taken, and the lipid droplet area per cell of 30-40 cells were measured for each distance range.
Vascular permeability assay
Macromolecular permeability of the endothelium in vascularized tissue was measured using a previous method [22] . Briefly, after 3-4 days of perfusion, media in the upper reservoir was replaced with perfusion media that was supplemented with 50 μg ml −1 Alexa Fluor 594-conjugated bovine serum albumin (BSA) and 20 μg ml −1 Alexa Fluor 488-conjugated 10 kDa dextran (both from Invitrogen). The tissue was placed in an environmental chamber at 37°C, and time-lapse images were captured every minute for thirty minutes in both red and green channels. Average gray values for the time-lapse images were measured using ImageJ and recorded. Permeability coefficients were determined using an algorithm to correct for the non-instantaneous filling of the vessel by fluorescent media [23] .
Adipocyte viability assay
Adipose tissues were disconnected from tubing after three days of perfusion. Perfusion media containing 10 μg ml −1 calcein AM, 10 μM ethidium homodimer, and 5 μg ml −1 Hoechst 33342 (all from Invitrogen) was added to the wells on either side of the tissue, allowed to flow through the vessel, and incubated for thirty minutes at 37°C. To first visualize viability of ECs, we captured images in green, red, and blue channels for live cells, dead cells, and nuclei, respectively, while focusing at the microvessel. The tissues were then carefully taken out of the PDMS mold and submerged in media containing live/dead stain for another thirty minutes. To visualize live and dead adipocytes, we captured images using the same excitation wavelengths while focusing on adipocytes in the collagen gel.
Staining
After one day of perfusion, the engineered tissues were fixed by perfusion with 4% paraformaldehyde (15 min, 20°C). Each tissue was then blocked and permeabilized with 5% goat serum and 0.5% Triton X-100 in PBS ('blocking buffer') for at least one hour.
To stain for the endothelial junctional marker CD31, we perfused the permeabilized tissue with 5 μg ml , measured on days 1-5 after gelling, p<0.05 for all days except day 3, figure 2(B) ). Elastic moduli and hydraulic permeabilities did not vary significantly with time, for both cell-free and adipocyte-containing collagen gels (p=0.59 and 0.88 for moduli and p=0.12 and 0.33 for hydraulic permeability, for cell-free and cell-laden gels, respectively). figure 3(A) ). The flow rate was initially ∼0.5 ml h −1 and increased to 1.6±0.3 ml h −1 after the channel widened. Staining for the EC junctional protein CD31 showed that the engineered tissue possessed confluent endothelium after one day of perfusion ( figure 3(B) ). We observed that the diameter of the vessels that were formed in adipocyte-containing gels varied across the lengths of the vessels. This result is in contrast to vessels that were formed in adipocyte-free collagen gel, which possessed smoothly tapering lumens across their lengths [18, 24] . The presence of adipocytes was confirmed by staining for neutral lipid with Nile Red ( figure 3(B) ). To prove that the adipocytes were viable, we stained the tissue with calcein AM and ethidium homodimer ( figure 3(C) ). We found a viability rate of >99% (n=3) for ECs and 93±3% (n=5) for adipocytes after three days of perfusion.
Engineered
To characterize the barrier function of the vessels, we carried out permeability assays on vessels in adipocytefree collagen gels and in adipocyte-containing collagen gels that were perfused under standard conditions, and in adipocyte-containing collagen gels that were perfused with media that was supplemented with 10 μg ml , respectively ( figure 3(E) ). Vessels that were formed in adipocyte-containing gels exhibited a three-fold increase in permeability to BSA compared to vessels in adipocyte-free gels, regardless of the presence of insulin and Intralipid (p<0.001 for adipocyte-free versus adipocyte-containing without supplements, p<0.01 for adipocyte-free versus adipocyte-containing with supplements). Perfusion with insulin and Intralipid did not change vessel permeability in adipocytecontaining gels (p=0.81, figure 3(E) ). Permeabilities to 10 kDa dextran were (1.3±0.4)×10 −6 cm s for the three conditions, respectively; again, the addition of adipocytes led to higher permeability (p<0.01), while insulin and Intralipid had no effect (p=0.97, figure 3(F) ).
Adipose tissues respond appropriately to lipogenic and lipolytic hormones
To examine the lipogenic response of vascularized adipose tissues, we switched some tissues to perfusion with media that contained insulin and Intralipid, starting on day 1. After four more days of perfusion, adipose tissues that were treated with insulin and Intralipid had clearly larger lipid droplets ( figure 4(A) ). The tissues showed a 72±18% increase in lipid droplet area per cell over four days, which is higher than the 24±22% increase in tissues that were perfused without lipogenic supplements (p<0.001, figure 4(B) ).
To examine the lipolytic response, we switched tissues that were previously perfused with insulin-and Intralipid-supplemented media to perfusion media with or without epinephrine, starting on day 5. After an additional four days of perfusion, tissues that were treated with epinephrine had shrunken lipid droplets (figure 4(C)); in contrast, tissues that were not perfused with epinephrine maintained their lipid droplets. Tissues that were perfused with epinephrinesupplemented media showed marked decrease (−33±3%) in lipid droplet area per cell over four days (p<0.001, compared to tissues perfused with media without epinephrine, figure 4(D) ). Eventually, the lipid droplets in epinephrine-treated tissues regressed to a size similar to those on day 1 of perfusion, i.e., before lipogenic or lipolytic supplements were added.
Vascular perfusion supports a gradient of adipocyte lipogenesis in centimeter-scale tissues
To better understand how the separation between adipocytes and the vessel affects adipocyte function, we formed tissues that extended up to 10 mm away from the vessel wall with two adipocyte densities. In these tissues, after seven days of perfusion (the last six days with insulin and Intralipid), adipocytes that were near the microvessel appeared visibly larger compared to those that were further away from the vessel ( figure 5(A) ). In tissues that contained 10 6 cells ml −1 , adipocytes that were within 1 mm from the vessel showed a 115±21% increase in lipid droplet area over six days, whereas adipocytes that were further than 9 mm away showed modest growth (21±13%, figure 5(B) ). In tissues that contained 1.5×10 6 cells ml −1 , adipocytes that were within 1 mm from the vessel showed a 105±23% increase over six days, whereas adipocytes that were further than 9 mm away showed essentially no growth ( figure 5(C) ). For both cell concentrations, most of the lipid accumulation occurred between days 1 and 5, with only little further growth from days 5 to 7.
Discussion
In this study, we engineered small-scale adipose tissues that contained perfusable microvessels. The tissues were formed by micromolding suspensions of differentiated 3T3-L1 adipocytes in type I collagen around an empty channel that subsequently served as a template for endothelialization. We found that adipocyte-laden collagen had ∼40% lower stiffness and ∼50% higher hydraulic permeability, compared to bare collagen gel. Although adding adipocytes to collagen reduced the collagen concentration, the change was small (∼3%), and it is unlikely that the observed differences in physical properties can be explained primarily by the dependence of stiffness and hydraulic permeability on gel concentration. Remodeling of collagen by embedded adipocytes may contribute to the physical changes. Accumulation of lipid over a span of up to five days in culture did not appear to alter the mechanical properties of the formed tissues. The measured stiffness of adipocyteladen collagen gel (∼180 Pa) was lower than that of native subcutaneous adipose tissue (2-3 kPa) [25, 26] , which is likely a result of the lower volume fraction of adipocytes in the gels. The stiffness could potentially be improved by incorporating larger adipocytes (e.g., human white adipocytes) at higher concentration.
The flow rates and vessel diameters in the current study were larger than those measured for vessels in adipocyte-free gels from previous work [18] , most likely because the adipocyte-containing gels were less stiff. Adding adipocytes to the collagen gel also resulted in a three-fold increase in vascular permeability to both BSA and 10 kDa dextran. This result can potentially be explained from the disruption of endothelial barrier function by free fatty acids [27] and by adipocyte-secreted permeability factors, such as vascular endothelial growth factor [28] and leptin [29] . The unevenness of the vascular profiles that we observed only in adipocyte-containing tissues may also have a permeability-enhancing effect. Differences in vascular shear stress, which can alter solute permeability [24] , are unlikely to be responsible here; from the measured flow rates, we estimated the average vascular shear stress to be ∼12 dyn cm −2 in adipocyte-containing samples and ∼13 dyn cm −2 in adipocyte-free samples.
The measured vascular permeability in adipocyteladen gel was comparable to mammalian venules of similar size (∼2×10 −6 cm s Insulin increases lipid accumulation in adipocytes through multiple pathways, including enhancing the conversion of circulating triacylglycerol to fatty acid [15] and increasing the uptake of free fatty acid by adipocytes [14] . Conversely, epinephrine accelerates the breakdown of stored triglyceride into free fatty acids during periods of high energy demand such as fasting or exercise [31] . Both hormones are important mediators of metabolic conditions such as obesity and diabetes. It is therefore important to show that engineered adipose tissue can respond appropriately to lipoactive hormones with lipogenesis or lipolysis. While many previous studies used either total lipid content [21, 32] or lipid droplet diameter [33] as a measure of lipid accumulation, neither method is suitable for the current study. The first method requires lysing the cells to release stored triglyceride, which prevents tracking adipocyte growth over time in the same sample. The second method is best-suited for unilocular adipocytes such as mature human white . (E) Measured and computed (predicted) adipocyte growth at day 7 in tissues with 1.5×10 6 adipocytes ml adipocytes and not for multilocular 3T3-L1 cells. We therefore measured change in lipid droplet area per cell as an indicator of lipogenesis and lipolysis. We observed ∼70% increase in lipid droplet area per cell in adipose tissue after four days of perfusion with insulin and Intralipid, whereas adipose tissue perfused without insulin and Intralipid only showed a ∼25% increase. While the effects of insulin and Intralipid were not studied separately, our findings indicate that the engineered adipose tissues responded to lipogenic compounds with increased lipid accumulation. Similarly, adipose tissues that were previously 'fattened' with insulin and Intralipid showed ∼30% decrease in lipid droplet area per cell upon removal of insulin/Intralipid and addition of epinephrine for four days, which is consistent with the lipolytic action of epinephrine. When switched to media that did not contain lipogenic or lipolytic compounds, adipocytes that were prefed with insulin and Intralipid neither shrunk nor showed further growth.
In wide adipose tissues that were fed by a single microvessel, adipocytes that were within 0-1 mm from the vessel showed roughly two-fold growth over six days in tissues at both high (1.5×10 6 cells ml
) and low (10 6 cells ml
) cell densities. The lipid accumulation was less for adipocytes that were further away from the vessel; for adipocytes that were the furthest (9-10 mm) from the vessel, little accumulation of lipid was observed. In low-density tissues, adipocytes that were 9-10 mm away from the vessels showed ∼20% growth. In high-density tissues, virtually no growth was observed in adipocytes that were 9-10 mm away from the vessel. Most of the lipid accumulation occurred in the first four days of perfusion with lipogenic supplements.
The plots of lipid accumulation versus distance suggest that diffusive transport of a lipogenic signal from the vessel to adipocytes far from the vessel was limited by consumption of the signal by adipocytes that were close to the vessel. We used a simple Kroghtype model to rationalize these plots. In this model, we assume that the lipogenic nutrient was taken up by adipocytes with first-order kinetics as it diffused from the vessel into the tissue. We also assume that lipid droplet accumulation was metabolized with firstorder kinetics. The underlying equations for lipid accumulation are:
where C is the concentration of lipogenic factors (insulin, Intralipid, etc) in the extracellular space, x is the distance away from the vessel, ρ is the density of adipocytes in the tissue, k up is the uptake rate of lipogenic factors by adipocytes, G is the accumulation of lipid, k prod is the rate at which adipocytes accumulate lipid in response to the lipogenic signal, and B is the rate at which adipocytes metabolize accumulated lipid. This model predicts that the steady-state lipid accumulation also decreases exponentially with distance, with a decay length that is inversely proportional to ρ figure 5(D) ). We then used equation (5) to predict the lipid accumulation profile of tissues with 1.5×10 6 3T3-L1 cells ml -1 by using the fitted coefficients and multiplying ρ by 1.5. The resulting curve yielded R 2 =0.67 ( figure 5(E) ). The reasonable agreement between experimental data and this model provides a quantitative tool to predict the lipid accumulation profile in adipose tissues that contain more complex vascular geometries, even without knowledge of the rate-limiting lipogenic factor or the metabolic constants.
Conclusion
We have described a method for engineering lipoactive adipose tissue with pre-patterned vasculature that allows immediate perfusion. Our design can accommodate both vascular and non-vascular cell types, and we believe it can serve as a building block for constructing larger tissues for potential future application in soft-tissue repair. The current tissue can be used as a 'fat-on-a-chip' microphysiological system to model vessel-adipocyte interactions. It can also be incorporated as one element of more complex adipose-rich tissues, such as in models of breast tumors [34] . To scale up the current tissue into a clinically implantable flap, we will need to modify these tissues so that they use primary human adipocytes or adiposederived stem cells, a branching vascular network that can support large tissues, and a robust vascular pedicle that can withstand suture anastomosis and perfusion at arterial pressures [35] .
